{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:31:13Z","timestamp":1779917473436,"version":"3.53.1"},"reference-count":46,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2019,1,2]]},"DOI":"10.1080\/13696998.2018.1539400","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T17:47:51Z","timestamp":1540403271000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective"],"prefix":"10.1080","volume":"22","author":[{"given":"Ron","family":"Goeree","sequence":"first","affiliation":[{"name":"Goeree Consulting Ltd and Professor Emeritus, McMaster University, Hamilton, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Chiva-Razavi","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Gunda","sequence":"additional","affiliation":[{"name":"Novartis Product Life Cycle Services-NBS, Novartis Healthcare Private Limited, Hyderabad, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal","family":"Jain","sequence":"additional","affiliation":[{"name":"Novartis Product Life Cycle Services-NBS, Novartis Healthcare Private Limited, Hyderabad, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen M.","family":"Jugl","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.188"},{"key":"CIT0002","first-page":"139","volume-title":"Harrison\u2019s rheumatology","author":"Taurog JD","year":"2005","edition":"16"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2014.10.007"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203582"},{"key":"CIT0005","first-page":"1779","volume":"31","author":"Heuft-Dorenbosch L","year":"2004","journal-title":"J Rheumatol"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31591-4"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-008-0060-3"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22959"},{"key":"CIT0010","first-page":"4","volume":"78","author":"Boonen A","year":"2006","journal-title":"J Rheumatol Suppl"},{"key":"CIT0011","first-page":"289","volume":"33","author":"Kobelt G","year":"2006","journal-title":"J Rheumatol"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"CIT0013","first-page":"665","volume":"42","author":"Rohekar S","year":"2014","journal-title":"J Rheumatol 2015"},{"key":"CIT0014","volume-title":"Cosentyx\u00ae Product Monograph","author":"Novartis Pharmaceuticals Canada Inc","year":"2016"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210023"},{"issue":"285","key":"CIT0017","volume":"19","author":"Pavelka K","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-018-0123-5"},{"key":"CIT0019","author":"Maksymowych WP","year":"2016","journal-title":"10th International Congress on Spondyloarthritides"},{"key":"CIT0020","unstructured":"Clinicaltrials.gov. Effect of secukinumab on radiographic progression in ankylosing spondylitis as compared to GP2017 (adalimumab biosimilar). 2017. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT03259074 [Last accessed January 2018]"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2016.1167183"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Keat A, Barkham N, Bhalla A, et\u00a0al. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Rheumatology 2005;44:939\u201347","DOI":"10.1093\/rheumatology\/keh669"},{"key":"CIT0023","volume-title":"NICE. TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: NICE Technology Appraisal 383","year":"2016"},{"key":"CIT0024","volume-title":"Golimumab for the treatment of ankylosing spondylitis. NICE Technology Appraisal 233","author":"NICE.","year":"2011"},{"key":"CIT0025","volume-title":"CADTH","year":"2007"},{"key":"CIT0026","first-page":"2286","volume":"21","author":"Garrett S","year":"1994","journal-title":"J Rheumatol"},{"key":"CIT0027","doi-asserted-by":"crossref","unstructured":"Baeten DPM, Strand V, McInnes I, et\u00a0al. Secukinumab for the treatment of ankylosing spondylitis: comparative effectiveness results versus currently licensed biologics from a network meta-analysis. Ann Rheum Dis 2016;75(suppl 2):809\u2013810","DOI":"10.1136\/annrheumdis-2016-eular.2044"},{"key":"CIT0028","volume-title":"NICE decision support unit technical support documents. A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials","author":"Dias S","year":"2014"},{"key":"CIT0029","unstructured":"Ontario Ministry of Health and Long-Term Care. Ontario drug benefit formulary\/comparative drug index. Ottawa, Ontario: Government of Canada; 2016. Available at: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/odbf\/odbf_except_access.aspx2016 [Last accessed May 5, 2016]"},{"key":"CIT0030","volume-title":"TNF-alpha inhibitors for ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of ankylosing spondylitis (including a review of technology appraisal 143 and technology appraisal 233","author":"Corbett MSM","year":"2014"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.3310\/hta20090"},{"key":"CIT0032","volume-title":"Consumer Price Index, historical summary (1996 to","author":"Statistics Canada","year":"2017"},{"key":"CIT0033","volume-title":"Probability of dying by age and sex","author":"Statistics Canada","year":"2009"},{"key":"CIT0034","volume-title":"for the Economic Evaluation of Health Technologies","author":"CADTH Guidelines","year":"2017"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.3310\/hta11280"},{"key":"CIT0036","volume-title":"NICE Technology Appraisal - Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors [TA 407]","author":"NICE.","year":"2016"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.768"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.2980"},{"key":"CIT0039","doi-asserted-by":"crossref","volume-title":"The cost-effectiveness of secukinumab versus tumour necrosis factor a inhibitor biosimilars for ankylosing spondylitis in the UK","author":"Marzo-Ortega H","DOI":"10.1093\/rheumatology\/kex062.108"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.765"},{"issue":"221","key":"CIT0041","volume":"20","author":"Djambazov S","year":"2017","journal-title":"Value Health"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.1117"},{"key":"CIT0043","volume-title":"Secukinumab demonstrates low radiographic progression and sustained efficacy through 4 years in patients with active ankylosing spondylitis [abstract]","author":"Braun JBX"},{"issue":"2","key":"CIT0044","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/annrheumdis-2018-eular.1396","volume":"77","author":"Baraliakos X","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"CIT0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/annrheumdis-2016-eular.2050","volume":"75","author":"Maksymowych W","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.764"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2018.1539400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:35:04Z","timestamp":1775252104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2018.1539400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,2]]}},"alternative-id":["10.1080\/13696998.2018.1539400"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2018.1539400","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}